Skip to content

The effect of garlic tablets on the pain of women with endometriosis

The effect of garlic tablets on the pain of women with endometriosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201501059463N34
Enrollment
120
Registered
2015-06-30
Start date
2015-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis. Other endometriosis

Interventions

Intervention 1: Intervention group: Use of oral tablets of 400 mg garlic per day with lunch for 12 weeks. Intervention 2: Control group: the use of 400 mg oral tablet with lunch starch as the placebo
Treatment - Drugs
Placebo
Intervention group: Use of oral tablets of 400 mg garlic per day with lunch for 12 weeks
Control group: the use of 400 mg oral tablet with lunch starch as the placebo for 12 weeks

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Endometriosis diagnosed by the Laparoscopy ? age of 20-45?having the pain associated with endometriosis?the absence of any other physical disorders or any known mental health problems? using the standard treatments of Hospital Valiasr? using the NSAID group of anti-pains? not having any sensitivity to garlic? not applied for the treatment of infertility? The exclusion criteria: The emergence of any known physical or mental illness during the study? the lack of daily consumption or misuse of garlic tablets by patients? unwillingness to continue the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 3Month. Method of measurement: vas.

Secondary

MeasureTime frame
Dyspareunia. Timepoint: 3Month. Method of measurement: vas.;Dysmenorrhea. Timepoint: 3month. Method of measurement: vas.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoodabhe

Amirsalari

sudisalari@gmail.com+98 21 6105 4215

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026